Three-Dimensional Polymer Fibre Scaffolds with Functional Nano-structured Surface. The Partner Organisation to this research, CyGenics Ltd, is a world leader in cell biotechnology. A key challenge faced by the CyGenics and other biotech companies is the provision of tissue scaffolding materials that have the right three-dimensional macroscopic structure plus a suitable nano-structured surface micro-environment, similar to the natural extracellular matrix. This joint project combines expertise in ....Three-Dimensional Polymer Fibre Scaffolds with Functional Nano-structured Surface. The Partner Organisation to this research, CyGenics Ltd, is a world leader in cell biotechnology. A key challenge faced by the CyGenics and other biotech companies is the provision of tissue scaffolding materials that have the right three-dimensional macroscopic structure plus a suitable nano-structured surface micro-environment, similar to the natural extracellular matrix. This joint project combines expertise in polymer fibres, surface engineering and cell culture to tackle the key challenge. The outcome will help position the local polymer fibre and cell culture industries at the forefront of tissue scaffolding materials research and development. Read moreRead less
The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the heal ....The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the health and well-being of Australians. The research falls within the Designated National Research Priority of Frontier Technologies for Building and Transforming Australian Industries.Read moreRead less